Program Fisioterapi Pada Atlet Setelah Infeksi Covid-19 Dengan Cardiac Problem Untuk Dapat Kembali Ke Olahraga : Studi Literatur
Physiotherapy Program in Athlete after Covid-19 Infection with Cardiac Problem for Return to Sport: Literature Review
Abstract
Covid-19 merupakan penyakit yang disebabkan oleh virus Sars-CoV-2 yang menyerang sistem pernafasan. Virus ini ternyata juga dapat menyebabkan komplikasi seperti renal failure dan cardiac problem. Setelah infeksi Covid-19 seorang atlet sangat bersiko mengalami cardiac problem dikarenakan olahraga intensitas tinggi yang mereka lakukan dapat meningkatkan penyebaran virus menuju jantung, inflamasi, kematian sel, dan aritmia. Oleh karena itu, pentingnya memastikan kondisi jantung atlet dalam kondisi normal sebelum kembali melakukan aktifitas fisik. Studi ini bertujuan untuk menjelaskan bagaimana Program fisioterapi pada Atlet yang memiliki Cardiac problem setelah infeksi Covid-19 untuk dapat kembali berolahraga. Penelitian ini menggunakan metode Literature review dengan strategi pencarian PICO Framework. Dari hasil pencarian didapatkan 1664 jurnal yang kemudian disaring menggunakan kriteria inklusi dan eksklusi sehingga didapatkan 5 jurnal untuk dilakukan sintesis. Hasil dari studi ini meliputi program fisioterapi pada atlet yang mengalami cardiac problem setelah infeksi Covid-19 yaitu program dengan intensitas Low to moderate yang dilakukan selama 3 sampai 6 bulan. Kesimpulan studi ini yaitu Ketika Atlet terinfeksi Covid-19 dan mengalami cardiac problem maka Program fisioterapi yang direkomendasikan berupa latihan dengan intensitas low to moderate untuk membantu atlet tetap mempertahankan kondisi kapasitas fungsionalnya dan memberi waktu pada jantung untuk recovery sehingga atlet dapat kembali berolahraga lagi.
Downloads
References
Alosaimi, B. et al. (2022) ‘Cardiovascular complications and outcomes among athletes with COVID-19 disease: a systematic review’, BMC Sports Science, Medicine and Rehabilitation, 14(1), pp. 1–10. doi: 10.1186/s13102-022-00464-8.
Calabrese, M. et al. (2021) ‘Exercise training and cardiac rehabilitation in covid-19 patients with cardiovascular complications: State of art’, Life, 11(3), pp. 1–16. doi: 10.3390/life11030259.
Daniels, C. J. et al. (2021) ‘Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes with Recent SARS-CoV-2 Infection: Results from the Big Ten COVID-19 Cardiac Registry’, JAMA Cardiology, 6(9), pp. 1078–1087. doi: 10.1001/jamacardio.2021.2065.
Eichhorn, C. et al. (2020) ‘Myocarditis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncertainties’, JACC: Cardiovascular Imaging, 13(2), pp. 494–507. doi: 10.1016/j.jcmg.2019.01.039.
Van Hattum, J. C. et al. (2021) ‘Cardiac abnormalities in athletes after SARS-CoV-2 infection: A systematic review’, BMJ Open Sport and Exercise Medicine, 7(4), pp. 1–11. doi: 10.1136/bmjsem-2021-001164.
Małek, Ł. A. et al. (2021) ‘Cardiac involvement in consecutive elite athletes recovered from Covid-19: A magnetic resonance study’, Journal of Magnetic Resonance Imaging, 53(6), pp. 1723–1729. doi: 10.1002/jmri.27513.
McKinney, J. et al. (2021) ‘COVID-19–Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group’, Canadian Journal of Cardiology, 37(8), pp. 1165–1174. doi: 10.1016/j.cjca.2020.11.007.
Modica, G. et al. (2022) ‘Myocarditis in Athletes Recovering from COVID-19 : A Systematic Review and Meta-Analysis’.
Moulson, N. et al. (2021) ‘SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes’, Circulation, pp. 256–266. doi: 10.1161/CIRCULATIONAHA.121.054824.
Pelliccia, A. et al. (2021) ‘2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease’, European Heart Journal, 42(1), pp. 17–96. doi: 10.1093/eurheartj/ehaa605.
Schellhorn, P., Klingel, K. and Burgstahler, C. (2020) ‘Return to sports after COVID-19 infection’, European Heart Journal, 41(46), pp. 4382–4384. doi: 10.1093/eurheartj/ehaa448.
Shi, S. et al. (2020) ‘Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China’, JAMA Cardiology, 5(7), pp. 802–810. doi: 10.1001/jamacardio.2020.0950.
Tschöpe, C. et al. (2021) ‘Myocarditis and inflammatory cardiomyopathy: current evidence and future directions’, Nature Reviews Cardiology, 18(3), pp. 169–193. doi: 10.1038/s41569-020-00435-x.
Vassalini, M. et al. (2016) ‘An autopsy study of sudden cardiac death in persons aged 1-40 years in Brescia (Italy)’, Journal of Cardiovascular Medicine, 17(6), pp. 446–453. doi: 10.2459/JCM.0000000000000234.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The use of the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution 4.0 International License.
Author’s Warranties
The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).
User Rights
JFR's spirit is to disseminate articles published are as free as possible. Under the Creative Commons license, JFR permits users to copy, distribute, display, and perform the work. Users will also need to attribute authors and JFR on distributing works in the journal.
Rights of Authors
Authors retain all their rights to the published works, such as (but not limited to) the following rights;
- Copyright and other proprietary rights relating to the article, such as patent rights,
- The right to use the substance of the article in own future works, including lectures and books,
- The right to reproduce the article for own purposes,
- The right to self-archive the article
Co-Authorship
If the article was jointly prepared by other authors, any authors submitting the manuscript warrants that he/she has been authorized by all co-authors to be agreed on this copyright and license notice (agreement) on their behalf, and agrees to inform his/her co-authors of the terms of this policy. JFR will not be held liable for anything that may arise due to the author(s) internal dispute. JFR will only communicate with the corresponding author.
Miscellaneous
JFR will publish the article (or have it published) in the journal if the article’s editorial process is successfully completed. JFR's editors may modify the article to a style of punctuation, spelling, capitalization, referencing and usage that deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers as mentioned in point 3.
